Fox Health

An endorsement from an independent group of experts and an emergency use authorization from the Food and Drug Administration would spark a rollout of up to 4 million jabs across the U.S. early next week.

A third COVID-19 vaccine could enter the fight against the novel virus in the coming days. But what does its safety profile look like?

A coronavirus vaccine developed by Johnson & Johnson could potentially clear U.S. regulatory hurdles over the next day, and authorization would mark the third jab in the country’s arsenal against the novel virus.

The coronavirus variant first detected in the U.K. late last year now accounts for up to 10% of COVID-19 cases in the U.S., officials said Friday.

Annie’s Homegrown, largely known for its macaroni and cheese, is taking steps to remove a potentially harmful class of chemicals, called ortho-phthalates from its products and packaging materials. 

Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages 12 to 17.

The Food and Drug Administration (FDA) said Thursday it is allowing more flexible shipping and storage temperatures for the Pfizer-BioNTech coronavirus vaccine. The change permits transportation and two-week storage at -25 degrees Celsius to -15 degrees Celsius, which is often found in pharmaceutical freezers and refrigerators. 

How would COVID-19 vaccine makers adapt to variants? By tweaking their vaccines, a process that should be easier than coming up with the original shots.

The Food and Drug Administration warning parents and caregivers against making or feeding infants homemade formula.

A study published Wednesday in the journal JAMA Internal Medicine suggests that those who have COVID-19 antibodies have a significantly lower risk of reinfection compared to those who do not have them. 

The Ad Council launches $500 million "It's Up to You" campaign aimed at educating people about the coronavirus vaccine.

New York City health officials on Thursday said there is no evidence showing the newly reported variant, B.1.526, is driving trajectory of infections, reduces vaccine efficacy or results in more severe illness.

Small pet turtles are behind a salmonella outbreak in Pennsylvania, according to state health officials who said at least one person has died as a result. 

Pfizer Inc. and BioNTech SE have begun a study testing in people whether the companies’ Covid-19 shot can provide protection against emerging strains of the coronavirus.

California is revamping its plan to help essential workers and seniors in underserved communities get coronavirus vaccinations after officials learned that appointment access codes were leaked to people who were not eligible for the shots.

A coronavirus vaccine developed by Pfizer and BioNTech showed to drop symptomatic COVID-19 by 94%, per new research out of Israel. The peer-reviewed results offer a first look at effectiveness in real-world conditions, and showed consistency with high 95% vaccine efficacy reported during clinical trials.

Researchers studying COVID-19 and its variants across the U.S. have expressed concern over a mutation found in New York City that could diminish the effectiveness of vaccines on the virus.

February is usually the peak of flu season, with doctors’ offices and hospitals packed with suffering patients. But not this year.

Moderna on Wednesday announced that the COVID-19 vaccine it recently developed to address a concerning new coronavirus variant first identified in South Africa is ready to be tested in people in clinical trials.

Outbreaks of the common cold could become more commonplace as schools reopen for in-person learning, according to a new report from the Centers for Diease Control and Prevention.